Return to site

Gregor Diagnostics Joins Health Wildcatter Accelerator

Madison, Wis. & Dallas, Texas, Aug. 30, 2017 – Gregor Diagnostics, a molecular diagnostics startup company based in Madison, Wis., that is developing a groundbreaking new screening test for prostate cancer, will participate in the 2017 Health Wildcatters accelerator program. Out of a broad field of applicants, Gregor Diagnostics has been selected as one of only 9 health care startups from across the country to participate in Health Wildcatters, a three-month program in Dallas. This program offers healthcare-focused startups in the early stages of funding an initial seed investment, as well as access to mentors, advisors, office space and strategic resources needed to help the startups grow.

 

“We are excited to be a part of this year’s Health Wildcatters program,” said Tobias Zutz, CEO of Gregor Diagnostics. “The warm reception from Health Wildcatters, its network, and the Dallas community has been very impressive. We’re ready to hit the ground running in Dallas and continue to move Gregor forward as we combat prostate cancer.”

 

“We are delighted to have Gregor Diagnostics join our healthcare accelerator,” said Hubert Zajicek, MD, MBA, CEO of Health Wildcatters. “Gregor is a fantastic company that is already advancing its new diagnostic test and we look forward to its further progress as a participant in our program.”

 

Founded in 2013 and based in Dallas, Health Wildcatters is a top ranked healthcare seed accelerator. The mentorship-driven accelerator has a mission to improve healthcare by supporting entrepreneurs and companies that are developing innovative solutions for the industry.

 

Contacts:

Tobias Zutz, Gregor Diagnostics

Tobias.zutz@gregordiagnostics.com

(920) 901-4950

 

Loren Bolton, Health Wildcatters

loren@healthwildcatters.com

(972) 674-9085

 

About Gregor Diagnostics

Gregor Diagnostics Inc. (www.gregordiagnostics.com) is a molecular diagnostics startup company developing a groundbreaking new screening test for prostate cancer. Gregor Diagnostics’ patient-friendly test will be the first diagnostic to detect prostate cancer at the earliest stages of the disease and differentiate between indolent and aggressive cancer. This will result in decreased overdiagnosis and overtreatment of indolent prostate cancer and more effective detection and management of aggressive prostate cancer.

About Health Wildcatters

Health Wildcatters, a Dallas-based mentor-driven, health care accelerator that offers a 12-week program geared toward health startups. Portfolio companies receive an initial seed investment, as well as access to mentors, advisors, office space and strategic resources required to help the startups grow. For more information, please visit www.healthwildcatters.com.

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly